Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycan epitopes on intestinal epithelial tissue are specific carbohydrate structures present on the surface of intestinal epithelial cells, primarily as part of glycoproteins and glycolipids. These glycans play crucial roles in maintaining mucosal barrier function, mediating host-microbe interactions, regulating immune responses, and supporting tissue homeostasis. Alterations in glycosylation patterns are associated with diseases like IBD and cancer, disrupting barrier integrity, altering microbial colonization, and impairing immune regulation.
Modulation of immune responses, disruption of microbial colonization, enhancement of epithelial repair mechanisms
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycan Epitopes on Intestinal Epithelial Tissue.